🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

A Pharma Stock with 21% Upside to Heal Your Portfolio

Published 18-06-2024, 11:01 am
GLAD
-

The pharma space has been doing quite well for the last few sessions with the Nifty Pharma index up 5% to 19,741 this month so far. Companies in this sector are also known for their strong resilience during a falling market and hence this sector is also called a defensive one.

But which company to include in the portfolio to reap the maximum benefit? The answer is simple - Undervalued stock with strong fundamentals. After going through the powerful “Strong Upside” screener (an exclusive feature of InvestingPro+), one stock that caught my attention is Gland Pharma (NS:GLAD) Limited.

Offer: Click here and discover the power of InvestingPro! Effortlessly access precise intrinsic stock values and detailed financial health scores using over 100 parameters. Grab our limited-time 69% discount now and make informed investment decisions with ease!

It is a midcap pharmaceutical company with a market capitalization of INR 31,062 crore. Mutual funds are in love with this counter as they hold a sizable 23.01% stake in the company, as of March 2024, up from 20.25% a year ago.

In FY24, the company clocked a record of INR 5,834.96 crore and it was able to make a net profit of INR 772.46 crore, securing a profit margin of 13.24%. Over the last 5 years, the average revenue growth has been 18.29%, beating the industry’s average of 8.34% by a significant margin.

Image Source: investingPro+

Now, let’s look at its financial health score in InvestingPro+ to see how all fundamentals stack up. A score of 3 out of 5 denotes good performance and this is the minimum we need to consider any stock for investment.

Image Source: investingPro+

But good fundamentals are not enough if the valuations are stretched. This is where the fair value feature comes in handy as it calculates intrinsic values by different models and compiles the result to arrive at a more realistic and bias-free true value. In this case, a total of 13 models have been used which indicate a fair value of INR 2,242 per share. With the current price of INR 1,841, there is a high upside of 21.8%.

Click here to unlock smarter investing with InvestingPro! Get accurate intrinsic stock values and comprehensive financial health scores, all without learning financial modeling. Take advantage of our 69% limited-time discount and simplify your investment decisions today, for just INR 216/month!

Read More: The Power of High-Quality Dividend Stocks with a "Screener"

X (formerly, Twitter) - Aayush Khanna

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.